Elevated levels of proinflammatory cytokines in patients with SRBD such as TNF-α, IL-6, IL-8, may exacerbate systemic inflammatory responses and, consequently, increase the vulnerability to RA [44–47]. The gene discussed is CXCL8; the disease is rheumatoid arthritis.